Stay updated on Lanabecestat in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Lanabecestat in Early Alzheimer's Disease Clinical Trial page
- ChecktodayChange DetectedThe web page has been updated to reflect a new version (v2.14.2) of the NLM-NCBI services and products, along with a notice about potential performance issues due to heavy traffic.SummaryDifference0.6%
- Check9 days agoChange DetectedA new study on the efficacy and safety of LY3314814 in early Alzheimer's disease has been added, providing more information for interested users.SummaryDifference0.3%
- Check16 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check24 days agoChange DetectedThe link to the study on the efficacy and safety of LY3314814 in early Alzheimer's disease has been removed.SummaryDifference0.3%
- Check31 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check52 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
Stay in the know with updates to Lanabecestat in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanabecestat in Early Alzheimer's Disease Clinical Trial page.